Nature’s Sunshine Cuts 2026 Sales and EBITDA Outlook

Q3 2026 net sales fell 9% to $116.6 million, while diluted EPS declined to $0.11 from $0.30 year over year. The company lowered 2026 net sales guidance to $460 million–$470 million from $490 million–$500 million and adjusted EBITDA guidance to $44 million–$48 million from $48 million–$52 million.